Announcing our patient grant fund to accelerate access to promising treatments, alongside with an Open-Source Treatment Registry, enabling rapid, compliant sharing of patient-driven insights.
We’ve been hearing more and more stories from patients who’ve been accessing promising treatments. Patients are moving faster than trials. But the outcomes aren’t being standardized and analyzed in a way that helps move research forward.
By encouraging rapid capital allocation, parallel adaptive trials, innovative intellectual property and licensing strategies and non-zero sum coordination mechanisms, we propose a framework for dramatically accelerating a cure for Long COVID.
Understanding Viral Persistence and Its Impact
Exploring Pemgarda and Paxlovid for Long COVID.
How We’re Using Community Input to Drive Long COVID Research
